Home
>
National Drug Code (NDC)
>
Oxcarbazepine
Oxcarbazepine - 51672-4105-3 - (Oxcarbazepine)
Drug Information of Oxcarbazepine
| Product NDC: | 51672-4105 |
| Proprietary Name: | Oxcarbazepine |
| Non Proprietary Name: | Oxcarbazepine |
| Active Ingredient(s): | 150 mg/1 & nbsp; Oxcarbazepine |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Oxcarbazepine
| Product NDC: | 51672-4105 |
| Labeler Name: | Taro Pharmaceuticals U.S.A., Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA077801 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20071115 |
Package Information of Oxcarbazepine
| Package NDC: | 51672-4105-3 |
| Package Description: | 1000 TABLET in 1 BOTTLE (51672-4105-3) |
NDC Information of Oxcarbazepine
| NDC Code | 51672-4105-3 |
| Proprietary Name | Oxcarbazepine |
| Package Description | 1000 TABLET in 1 BOTTLE (51672-4105-3) |
| Product NDC | 51672-4105 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Oxcarbazepine |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20071115 |
| Marketing Category Name | ANDA |
| Labeler Name | Taro Pharmaceuticals U.S.A., Inc. |
| Substance Name | OXCARBAZEPINE |
| Strength Number | 150 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE] |
